Clinical trial NCT04524429: Quality of Life After Bariatric Surgery
Official title: Quality of Life After Bariatric Surgery
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Bariatric Surgery Candidate
Obesity
Obesity, Morbid
Quality of Life
Lead sponsor: University of Adelaide
Sponsor class: OTHER
Collaborators: name: Central Adelaide Local Health Network Incorporated
First posted: 2020-08-24
Enrollment: 300
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: RETROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Pre-operative Group The pre-operative population will be patients who have been referred to TQEH bariatric clinic however have not yet had their initial appointment. The 150 participants who have been on the waiting list for the longest period of time will be included in the pre-operative group.

Post-operative Group The post-operative population will be the 140 patients who underwent bariatric surgery at TQEH between 2008 and 2018. This resulted in 146 operations.

Brief summary: This study aims to assess long term outcomes for patients who have underwent bariatric surgery. In particular, it aims to assess the quality of life of these participants.


Eligibility criteria: Inclusion Criteria:

* Obese, either received bariatric surgery or have been referred for bariatric surgery.

Exclusion Criteria:

* Emergency cases, Obese patients who have not been referred for bariatric surgery.

Primary outcomes:
measure: Quality of life before and after bariatric surgery
timeFrame: This represents the patients current quality of life within the last 4 weeks.
Secondary outcomes:
measure: Current Weight
timeFrame: This is the patients current weight within the last 4 weeks
measure: Lowest Weight
timeFrame: Retrospectively reviewed on average of 5 years
measure: Change in marker of Type 2 Diabetes Mellitus
timeFrame: Preoperative use compared to results within the last 4 weeks
measure: Change in marker of hypertension
timeFrame: Preoperative use compared with use in the last 4 weeks
measure: Change in marker of hyperlipidemia
timeFrame: Preoperative use compared with use in the last 4 weeks
measure: Change in marker of GORD
timeFrame: Preoperative use compared with use in the last 4 weeks
measure: Change in marker of OSA
timeFrame: Preoperative use compared with use in the last 4 weeks
Other outcomes:
Locations:
city: Adelaide
country: Australia
facility: The Queen Elizabeth Hospital
state: South Australia
Study officials:
affiliation: University of Adelaide, Central Adelaide Local Health Network
name: Antonio Barbaro, MBBS
role: PRINCIPAL_INVESTIGATOR
affiliation: Central Adelaide Local Health Network
name: Matheesha Herath, MBBS
role: PRINCIPAL_INVESTIGATOR
affiliation: Central Adelaide Local Health Network
name: Raghav Goel, MBBS
role: PRINCIPAL_INVESTIGATOR
affiliation: Central Adelaide Local Health Network
name: Gayatri Asokan, MBBS, FRACS
role: PRINCIPAL_INVESTIGATOR
affiliation: Central Adelaide Local Health Network
name: Markus Trochsler, MD, FMH, MMIS, FRACS
role: STUDY_DIRECTOR
affiliation: Central Adelaide Local Health Network
name: Harsh Kanhere, MS, FRACS, AFRACMA
role: STUDY_DIRECTOR
References: